GeoVax Provides Nasdaq Listing Update and Reaffirms Focus on Advancing Strategic Priorities

ATLANTA, GA - September 10, 2026 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing vaccines and immunotherapies against high-consequence infectious diseases and solid tumor cancers, today provided an...